# https://www.tianmingpharm.com > Leading manufacturer of APIs and pharmaceutical intermediates ## Posts - [Finerenone Mechanism of Action: A Non-Steroidal MRA Built Differently](https://www.tianmingpharm.com/finerenone-mechanism-of-action-a-non-steroidal-mra-built-differently/): Finerenone mechanism of action: a non‑steroidal mineralocorticoid receptor antagonist with high MR selectivity, balanced cardiorenal distribution, no active metabolites, and lower hyperkalemia risk vs steroidal MRAs. - [Clascoterone vs Minoxidil: How They Actually Compare for Hair Loss](https://www.tianmingpharm.com/clascoterone-vs-minoxidil-hair-loss/): Clascoterone vs minoxidil: Compare mechanisms, Phase 3 trial data, side effects, and whether they work better together. Evidence-based overview for hair loss. - [Finerenone vs Spironolactone: A Head-to-Head Look at Safety and Efficacy](https://www.tianmingpharm.com/finerenone-vs-spironolactone-comparison/): Finerenone vs spironolactone: head-to-head real-world data shows finerenone has 69% lower mortality, 53% fewer kidney events, and less hyperkalemia. Nonsteroidal MRA with no hormonal side effects. - [Clascoterone for Hair Loss: What the Phase 3 Data Actually Show](https://www.tianmingpharm.com/clascoterone-for-hair-loss-phase-3-data/): Clascoterone for hair loss: Phase 3 trials show significant regrowth with minimal systemic absorption. How it works, side effects, and comparison to finasteride. - [Does GLP-1 Cause Hair Loss? What I Learned From Reading the Studies](https://www.tianmingpharm.com/does-glp-1-cause-hair-loss/): Does GLP-1 cause hair loss? Yes, studies on 1.1M+ patients show an association—driven by rapid weight loss, not direct drug toxicity. Telogen effluvium is temporary. New oral drug Foundayo (orforglipron) included. - [Orforglipron vs Tirzepatide: A Data Driven Comparison](https://www.tianmingpharm.com/orforglipron-vs-tirzepatide-comparison/): Comparing orforglipron vs tirzepatide: tirzepatide shows greater weight loss (-20.9% vs -12.4%), but orforglipron offers oral dosing, easier manufacturing, and potential for better long-term adherence. - [Orforglipron for Sale: What Buyers Actually Need to Know Before Sourcing This GLP-1 Intermediate](https://www.tianmingpharm.com/orforglipron-for-sale-buyers-guide/): Looking for orforglipron for sale? This guide covers critical quality attributes—chiral purity, impurity control, and cGMP compliance—for sourcing GLP-1 intermediates. Learn what to ask suppliers before you buy. - [GLP-1 for Weight Loss: How These Drugs Work and What the Latest Data Shows](https://www.tianmingpharm.com/glp-1-weight-loss-guide/): This article elucidates the mechanism of action of GLP-1, the clinical data—including real-world efficacy and side effects—of drugs approved as of 2025 and novel oral therapies, their applicable patient populations, and their impact on the pharmaceutical supply chain. - [High-Purity Diabetes Drug Intermediates | SGLT2, GLP-1 & Orforglipron](https://www.tianmingpharm.com/diabetes-drug-intermediates-sglt2-glp1-orforglipron/): It clarifies the core differences between SGLT2 inhibitors and GLP-1 receptor agonists, covering their mechanisms, clinical advantages and representative products. It highlights Orforglipron, a breakthrough oral small-molecule GLP-1 agonist. - [Essential Documentation for Regulatory Submission of Intermediates (DMF/CEP)](https://www.tianmingpharm.com/essential-documentation-dmf-cep-intermediates/): Master regulatory submission for pharmaceutical intermediates with DMF/CEP documentation best practices. Fix common deficiencies, align with FDA/EDQM guidelines, and streamline review processes. - [Cortexolone 21-Acetate](https://www.tianmingpharm.com/cas-640-87-9-cortexolone-21-acetate/): CAS No. 640-87-9 - [Hydrogenation in Pharmaceutical Intermediates: Risks and Solutions](https://www.tianmingpharm.com/hydrogenation-pharmaceutical-intermediates-risks-solutions/): This article breaks down 4 core risks with authoritative industry data, and shares full-process, FDA & ICH-aligned solutions to reduce accidents, improve yields and ensure compliance. - [Technology Transfer Pitfalls in Intermediate Projects: Avoid Costly Mistakes](https://www.tianmingpharm.com/technology-transfer-pitfalls-intermediate-projects/): This article breaks down the 4 most costly mistakes — including incomplete documentation and ignored scalability — with verified industry data and real cases. - [A Comprehensive Supply Chain for Core Intermediates in Diabetes Treatment](https://www.tianmingpharm.com/anti-diabetic-intermediates-supply/): End-to-end supply chain for anti-diabetic intermediates. Covering DPP-4, SGLT-2 inhibitors & GPR40 agonists. Stable, compliant, scalable. - [Suzetrigine](https://www.tianmingpharm.com/suzetrigine/): CAS No. 2649467-58-1 - [CDMO vs. Direct Manufacturer: Which Model Fits Your API Strategy?](https://www.tianmingpharm.com/cdmo-vs-direct-manufacturer-api-strategy/): Drawing from on-the-ground experience in China's top pharma clusters, this guide cuts through the jargon to reveal when to partner for complex innovation and when to buy from the workhorses of mature production. - [Case Study: Improving Yield & Purity Through Route Optimization](https://www.tianmingpharm.com/api-route-optimization-yield-purity-case-study/): This case study, based on publicly available academic literature and patents, focuses on the application of synthetic route optimization in improving the yield and purity of Active Pharmaceutical Ingredients (APIs). - [Handling Hazardous Reactions During Intermediate Synthesis](https://www.tianmingpharm.com/handling-hazardous-reactions-intermediate-synthesis/): Learn how to manage hazardous reactions during intermediate synthesis with risk assessment, process control, and safety management strategies. - [Continuous Manufacturing vs. Batch Manufacturing: The Real Choice Logic in the Pharmaceutical Intermediate Stage](https://www.tianmingpharm.com/continuous-vs-batch-manufacturing-intermediates/): Compare continuous and batch manufacturing for pharmaceutical intermediates, focusing on cost, quality control, scalability, and supply chain risk. - [Supply Chain Risk Management for Intermediates](https://www.tianmingpharm.com/supply-chain-risk-management-for-intermediates/): Real-world insights into supply chain risk management for pharmaceutical intermediates, focusing on dual supply systems, critical raw material assurance, and compliance-driven supplier selection. - [Removing Catalyst Residues in Hydrogenation Intermediates](https://www.tianmingpharm.com/removing-catalyst-residues-hydrogenation-intermediates/): This article explains practical approaches to controlling residual metals through catalyst selection, reaction optimization, and downstream workup design. - [Solvent Selection and Recovery: Practical Experience and Reflections in Intermediate Synthesis](https://www.tianmingpharm.com/solvent-selection-recovery-intermediate-synthesis/): This article shares practical insights on solvent choice, recovery feasibility, safety, and compliance based on real manufacturing experience. - [Process Safety Considerations in Intermediate Manufacturing](https://www.tianmingpharm.com/process-safety-considerations-intermediate-manufacturing/): This article shares practical, experience-based insights into how safety risks emerge during intermediate production and how they can be effectively managed through thoughtful process design, hazard evaluation, and operational controls. - [Why More Pharma Companies Outsource Intermediate Manufacturing](https://www.tianmingpharm.com/why-more-pharma-companies-outsource-intermediate-manufacturing/): Why more pharma companies outsource intermediate manufacturing is no longer just a cost question. Based on real project experience, this article explains how outsourcing intermediates helps drug developers improve speed, manage impurity risk, and maintain regulatory control while focusing on core innovation. - [Analytical Method Development for Intermediate Purity & Impurities](https://www.tianmingpharm.com/analytical-method-development-intermediate-purity-impurities/): This article shares practical, field-based experience on designing robust analytical methods for complex intermediates, focusing on impurity identification, method robustness, and regulatory expectations. - [The Rise of High-Potency Intermediates: Manufacturing Challenges and Control](https://www.tianmingpharm.com/the-rise-of-high-potency-intermediates/): The Rise of High-Potency Intermediates highlights a fundamental shift in pharmaceutical manufacturing, where potency-related risks emerge early at the intermediate stage. As oncology and targeted therapies expand, manufacturers must integrate exposure control, impurity strategy, and scalable process design to ensure compliance, safety, and long-term supply reliability. - [Core Considerations in Designing Complex Pharmaceutical Intermediate Synthesis Routes: Practical Notes from the Field](https://www.tianmingpharm.com/complex-pharmaceutical-intermediate-synthesis-routes/): This article shares real-world insights from two decades of pharmaceutical process development, focusing on how synthesis route design for complex intermediates directly impacts cost, scalability, impurity control, and regulatory compliance. - [Cardiovascular Drug Intermediates: In-Depth Analysis of Key Compounds and Market Demand](https://www.tianmingpharm.com/intermediates-for-cardiovascular-drugs-market-demand/): Explore key pharmaceutical intermediates for cardiovascular drugs, manufacturing requirements, and global market demand supported by regulatory and industry data. - [Crystallization & Solid Form Challenges for Intermediates](https://www.tianmingpharm.com/crystallization-solid-form-challenges-pharmaceutical-intermediates/): Crystallization and solid-form control are critical to intermediate quality, scalability, and downstream API performance. This article explores common solid-state challenges, scale-up risks, and why early crystallization expertise at the intermediate stage reduces development and regulatory uncertainty. - [Orforglipron: A New Oral GLP-1 Option Redefining Weight Management](https://www.tianmingpharm.com/orforglipron-oral-glp1-weight-loss-drug/): Orforglipron is Eli Lilly’s oral GLP-1 receptor agonist for weight management, currently under FDA review. This article examines its clinical background, weight-maintenance data, and implications for pharmaceutical development and intermediates. - [Batch-to-Batch Consistency: Why It Matters for Intermediates](https://www.tianmingpharm.com/batch-to-batch-consistency-intermediates-manufacturing/): Learn why batch-to-batch consistency is critical for pharmaceutical intermediates, impacting impurity control, scale-up success, and regulatory compliance. - [Oncology Intermediates: Technical Challenges & Quality Expectations](https://www.tianmingpharm.com/oncology-intermediates-technical-challenges-quality-expectations/): This article examines the core technical challenges faced during oncology intermediate manufacturing, including reaction selectivity control, impurity structural fixation, and scale-up consistency risks. - [Scale-Up Challenges for Intermediates: Ensuring a Smooth Transition from Lab to Commercial Production](https://www.tianmingpharm.com/scale-up-challenges-for-intermediates/): This article provides an in-depth analysis of the most common scale-up challenges encountered during the production of pharmaceutical intermediates. - [Impurity Control in Pharmaceutical Intermediates: Insights from a Production Perspective](https://www.tianmingpharm.com/impurity-control-in-pharmaceutical-intermediates/): Learn proven, production-level strategies for impurity control in pharmaceutical intermediates. This guide explains impurity sources, control methods, and batch consistency practices. - [Global API Intermediates Suppliers List: A Reality-Based Industry Overview](https://www.tianmingpharm.com/global-api-intermediates-suppliers-list-2025/): Explore a verified global API intermediates suppliers list for 2025. Data-driven insights on leading manufacturers, regional strengths, and compliant sourcing strategies. - [Pharmaceutical Intermediate Quality Standards: A Practical Guide](https://www.tianmingpharm.com/pharmaceutical-intermediate-quality-standards/): Learn the essential pharmaceutical intermediate quality standards for 2025, based on ICH, GMP, and global regulatory frameworks to ensure compliance and reliability. - [Highly Potent Active Pharmaceutical Ingredients (HPAPIs): What They Are and Why They Matter in Modern Drug Development](https://www.tianmingpharm.com/highly-potent-active-pharmaceutical-ingredients-hpapis-guide/): This article explains what HPAPIs are, why they are increasingly important, and the safety and containment technologies required for compliant manufacturing. - [Production Processes for Pharmaceutical Intermediates: Core Procedures for Ensuring Quality and Safety](https://www.tianmingpharm.com/pharmaceutical-intermediates-manufacturing-process-guide/): This article provides a comprehensive overview of the pharmaceutical intermediates manufacturing process, covering core steps such as raw material sourcing, multi-step synthesis, purification, and quality control. - [Top 10 Oncology Intermediates Shaping the Future of Cancer Treatment in 2025](https://www.tianmingpharm.com/top-oncology-intermediates-2025/): A concise overview of the top 10 oncology intermediates expected to drive cancer therapy innovation in 2025, including PROTAC, ADC linkers, PARP cores, and radiopharmaceutical chelators. - [Industry News | No Need to Tough It Out in Prediabetes!](https://www.tianmingpharm.com/prediabetes-natural-supplement-clinical-results/): A randomized clinical trial found that a citrus-grape-hesperidin-chromium supplement improved fasting glucose in 3 months and significantly enhanced lipid profiles in prediabetic adults over 6 months. - [Orforglipron Heralds a New Era in Anti-Diabetes | Beyond Medication: Other Factors That Control Blood Sugar](https://www.tianmingpharm.com/orforglipron-blood-sugar-management-tips/): Discover how Orforglipron and smart breakfast choices improve blood-sugar control, boost energy, and reduce diabetes risk. Learn science-backed strategies today. - [Data Integrity Challenges in Intermediate Manufacturing: Building Trust Through Transparency](https://www.tianmingpharm.com/data-integrity-in-intermediates-manufacturing/): Discover key data integrity challenges in pharmaceutical intermediates manufacturing and learn practical strategies to ensure compliance, reliability, and patient safety. - [How to Verify Pharmaceutical Intermediates Supplier Compliance: A Practical Guide for Quality Professionals](https://www.tianmingpharm.com/verify-pharmaceutical-intermediates-supplier-compliance/): This guide shares real-world insights on auditing suppliers, detecting data integrity risks, and validating quality systems. - [Advanced Pharmaceutical Intermediates for CDMOs: Driving Innovation and Efficiency in Drug Development](https://www.tianmingpharm.com/advanced-pharmaceutical-intermediates-for-cdmo/): This article explores how advanced pharmaceutical intermediates empower CDMO partnerships by enhancing drug development speed, quality, and efficiency. - [Smarter Spending: How to Reduce Pharmaceutical Intermediate Costs Without Compromising Quality](https://www.tianmingpharm.com/reduce-pharmaceutical-intermediate-costs/): This article explores practical ways to reduce pharmaceutical intermediate costs through smarter supply chain management, optimized synthesis routes, process intensification, and green chemistry. - [Tianming Pharmaceutical Group Invites You to the 93rd China International API, Intermediate, Packaging & Equipment Fair](https://www.tianmingpharm.com/tianming-pharma-at-cphi-china-2025-booth-n5m07/): Tianming Pharmaceutical Group will participate in the 93rd China International Pharmaceutical Ingredients and Intermediates Exhibition (CPhI China 2025) from November 12–14 at the Chongqing International Expo Center, Booth N5M07. - [Frequently Asked Questions about Orforglipron: A Synthetic Chemist's Practical Guide](https://www.tianmingpharm.com/frequently-asked-questions-about-orforglipron-a-synthetic-chemists-practical-guide/): This guide explores its molecular mechanism, clinical performance, dosage strategy, side effects, and synthesis challenges from a chemist’s real-world perspective. - [Five Key Elements of Pharmaceutical Intermediate Quality Control](https://www.tianmingpharm.com/five-key-elements-of-pharmaceutical-intermediate-quality-control/): This article explores five critical elements that define successful quality systems.Tianming Pharmaceutical Group, quality is treated not as a cost but as an investment, ensuring every intermediate meets global GMP standards for consistency, purity, and performance. - [How to Select a GMP-Certified Pharmaceutical Intermediates Supplier (Authoritative Guide)](https://www.tianmingpharm.com/gmp-certified-pharmaceutical-intermediates-supplier/): This guide explains how to assess supplier quality systems, manufacturing technology, and reliability — helping pharmaceutical companies secure a trusted partner for long-term success. - [Chiral Intermediates: Unraveling the Molecular Asymmetry That Defines Modern Pharmaceuticals](https://www.tianmingpharm.com/chiral-intermediates-molecular-asymmetry-pharmaceuticals/): Explore chiral intermediates in drug development, their synthesis, industrial challenges, and AI-driven innovations shaping modern pharmaceuticals. - [Active Pharmaceutical Ingredient (API) Manufacturing Process Explained: From Laboratory to Commercial Production](https://www.tianmingpharm.com/active-pharmaceutical-ingredient-manufacturing-process/): The active pharmaceutical ingredient (API) manufacturing process is the foundation of modern drug development. This article provides an in-depth overview of the API manufacturing process and highlights why it is central to the pharmaceutical industry. - [Which of the Three Anti-Aging Ingredients is the Best: AKG, PQQ, or Ergothioneine?](https://www.tianmingpharm.com/akg-vs-pqq-vs-ergothioneine-anti-aging/): By understanding their strengths and differences, consumers can identify which ingredient best fits their personal health goals - [Custom API Synthesis: Driving Innovation in Modern Drug Discovery](https://www.tianmingpharm.com/custom-api-synthesis-driving-innovation-in-modern-drug-discovery/): Custom API synthesis is transforming modern drug development by offering flexible, scalable, and GMP-compliant solutions. Partner with us to accelerate innovation and bring breakthrough medicines to market faster. - [2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene](https://www.tianmingpharm.com/canagliflozin-intermediate-cas-1030825-20-7/): CAS No. 1030825-20-7 - [Avibactam Intermediates in Stock | Full Range & Reliable Supply](https://www.tianmingpharm.com/avibactam-intermediates-supplier/): Shandong Tianming Pharmaceutical stands at the forefront of this field, achieving large-scale commercial production of key Avibactam intermediates with advanced synthesis technology and rigorous quality control. - [5-bromo-4-fluoro-1-methyl-1H-indazole](https://www.tianmingpharm.com/5-bromo-4-fluoro-1-methyl-1h-indazole/): CAS No. 1784678-61-0 - [(S)-1-(4-fluoro-2-methyl-2H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1H-imidazol-2(3H)-one](https://www.tianmingpharm.com/s-1-4-fluoro-2-methyl-2h-indazol-5-yl-imidazol-2-3h-one-cas-2212022-56-3/): CAS No. 2212022-56-3 - [Pharmaceutical Excipients: A Key Cornerstone in Modern Pharmaceutical Processing](https://www.tianmingpharm.com/pharmaceutical-excipients-a-key-cornerstone-in-modern-pharmaceutical-processing/): Pharmaceutical excipients, once seen as fillers, are now vital in drug formulation. They enhance stability, solubility, and patient compliance, while supporting safe, effective, and sustainable drug development. - [What is pharmacovigilance?](https://www.tianmingpharm.com/what-is-pharmacovigilance/): Pharmacovigilance is more than just monitoring adverse drug reactions—it is a dynamic safety system that directly involves API manufacturers. Changes in impurities, synthesis routes, or process modifications can affect drug safety and trigger regulatory scrutiny. - [How Does Orforglipron Work : Analysis of the Mechanism of Action of Orforglipron](https://www.tianmingpharm.com/how-does-orforglipron-work-analysis-of-the-mechanism-of-action-of-orforglipron/): Orforglipron is the first oral, non-peptide GLP-1 agonist with high bioavailability and strong efficacy in lowering glucose and weight. Precise synthesis and high-quality intermediates are crucial to ensure its success in drug development. - [Drugs vs. Health Foods—Understanding the Difference in One Article](https://www.tianmingpharm.com/drugs-vs-health-foods-understanding-the-difference-in-one-article/): Confused about the difference between drugs and health foods? This article explains their regulatory definitions, registration requirements, R&D costs, side effects, and consumer positioning. Understanding these distinctions helps consumers make smarter health decisions. - [Which Foods Contain PQQ in Daily Life?](https://www.tianmingpharm.com/which-foods-contain-pqq-in-daily-life/): Learn which foods are rich in PQQ and how to maintain a balanced intake. Adding these foods to your diet helps enhance cognitive function, fight fatigue, and protect overall health. - [The EU Plans to Approve NMN as a New Food: a Major Turning Point in the Regulation of Anti-aging Ingredients?](https://www.tianmingpharm.com/nmn-eu-approval-a-breakthrough-in-anti-aging-nutrition/): The European Food Safety Authority (EFSA) has begun the approval process for NMN as a novel food, marking a breakthrough in global compliance. This milestone may accelerate NMN’s role in anti-aging, energy metabolism, and health supplements, shaping a new era in nutrition and wellness. - [Brand-Name Drugs vs Generics vs APIs: What You Must Know](https://www.tianmingpharm.com/brand-name-drugs-vs-generics-vs-apis-what-you-must-know/): This guide clarifies distinctions between brand-name drugs, generics, and APIs, emphasizing bioequivalence, cost efficiency for chronic conditions, and safety warnings. - [We cordially invite you to visit Tianming Pharmaceutical Group's booth at CPHI Shenzhen - 9A02.](https://www.tianmingpharm.com/we-cordially-invite-you-to-visit-tianming-pharmaceutical-groups-booth-at-cphi-shenzhen/): Tianming Pharmaceutical Group (Booth 9A02) will exhibit at CPHI Shenzhen 2025 (Sept 1-3, Futian). Visit us for quality-focused supply chain solutions and collaborative opportunities. - [Continuous Flow Manufacturing Technology: A Revolutionary Approach to API and Intermediate Production](https://www.tianmingpharm.com/continuous-flow-manufacturing-technology-a-revolutionary-approach-to-api-and-intermediate-production/): Explores Continuous Flow Manufacturing (CFM) in pharma: precision, efficiency, sustainability. Benefits: real-time control, cost savings, eco-compliance. Case studies highlight productivity gains. - [Posaconazole vs Voriconazole: Understanding the Key Differences in Antifungal Therapy](https://www.tianmingpharm.com/posaconazole-vs-voriconazole-understanding-the-key-differences-in-antifungal-therapy/): Compare Posaconazole vs Voriconazole on spectrum, uses, safety, and formulation. Learn which antifungal suits your needs and why quality intermediates matter. - [Certificate of Analysis (COA) for Active Pharmaceutical Ingredients (API): The Authoritative Guide to Quality Assurance](https://www.tianmingpharm.com/certificate-of-analysis-for-active-pharmaceutical-ingredients-the-authoritative-guide-to-quality-assurance/): This guide details COA structure (identity, quality, scientific data, compliance), verification checks, common errors, and future-proofing strategies like blockchain tracking. Request a sample COA to streamline your quality processes. - [Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate: A 20-Year Veteran Synthetist's Perspective on the Evolution of These Drugs](https://www.tianmingpharm.com/tenofovir-alafenamide-vs-tenofovir-disoproxil-fumarate-a-20-year-veteran-synthetists-perspective-on-the-evolution-of-these-drugs/): This expert-authored article compares TAF vs TDF, emphasizing chemical design, safety, & clinical benefits. - [COA Verification Tools: How to Spot a Fake Certificate of Analysis (and Why It Matters)](https://www.tianmingpharm.com/coa-verification-tools-how-to-spot-a-fake-certificate-of-analysis-and-why-it-matters/): Chemical & pharma buyers: Fake COAs risk safety and compliance. Learn manual verification red flags + digital COA verification tools (supplier portals, QR codes, blockchain). Protect operations with trusted API/intermediate suppliers offering transparent, verifiable COAs. - [Pharmaceutical Intermediates Manufacturers: The Indispensable Hidden Champions in the Global Pharmaceutical Supply Chain](https://www.tianmingpharm.com/pharmaceutical-intermediates-manufacturers-the-indispensable-hidden-champions-in-the-global-pharmaceutical-supply-chain/): This article explores the critical role of pharmaceutical intermediates manufacturers in global drug production, emphasizing GMP compliance, custom synthesis capabilities, and regulatory expertise. It guides readers on evaluating suppliers based on quality, innovation, and supply chain reliability to optimize API development. - [The Oral Revolution: How Orforglipron Is Ending the Era of Injections and Redefining the New Standard for Weight Loss Medications?](https://www.tianmingpharm.com/the-oral-revolution-how-orforglipron-is-ending-the-era-of-injections-and-redefining-the-new-standard-for-weight-loss-medications/): Orforglipron, an oral GLP-1 agonist, overcomes injection limitations with 29-49h half-life and enzyme resistance. Phase II/III trials show 14.7% weight loss and 1.48% HbA1c reduction. Tianming Pharma provides certified intermediates. - [Ergothioneine for Skincare: Antioxidant & Anti-Aging Benefits, Selection Tips & Synergies](https://www.tianmingpharm.com/ergothioneine-skin-benefits-antioxidant-anti-aging-effects/): Ergothioneine (EGT) delivers comprehensive skin benefits via antioxidant, anti-inflammatory, photoprotective, and collagen-stimulating actions. - [Unraveling the Crucial Connection Between Ergothioneine and Health](https://www.tianmingpharm.com/blog-unraveling-the-crucial-connection-between-ergothioneine-and-health/): Ergothioneine, hailed as the "Longevity Vitamin," targets mitochondria via OCTN1 transporters, offering unparalleled antioxidant, anti-fatigue, and anti-aging effects. Tianming Pharma details L-form purity (>99.99%), glutathione synergy, and science-backed alternatives like NMN/PQQ. - [Structural Analysis of Orforglipron: The Molecular Wisdom Behind the Oral Weight-Loss Drug Revolution](https://www.tianmingpharm.com/structural-analysis-of-orforglipron-the-molecular-wisdom-behind-the-oral-weight-loss-drug-revolution/): Orforglipron's non-peptide scaffold (23 atoms) enables oral GLP-1 therapy via acid-stable triazole core, (R)-chlorophenyl chiral targeting, and pyridine N-oxide H-bonding. Tianming Pharma provides key intermediates for scalable synthesis. - [Breaking Through: Tianming Pharmaceutical Achieves Commercial Production of orforglipron Intermediates](https://www.tianmingpharm.com/breaking-through-tianming-pharmaceutical-achieves-commercial-production-of-orforglipron-intermediates/): We have made a major breakthrough in the production of orforglipron intermediates. We now offer a range of orforglipron intermediates with detailed information. Please contact us for more information to meet your pharmaceutical needs. - [2025 Pharma Intermediates Market Outlook: Disruptions, Growth Drivers, and Strategic Imperatives](https://www.tianmingpharm.com/2025-pharma-intermediates-market-outlook-disruptions-growth-drivers-and-strategic-imperatives/): This article examines six pivotal trends reshaping the 2025 pharma intermediates sector: Asia's manufacturing evolution, continuous production adoption, AI-driven R&D acceleration, ESG compliance pressures, nearshoring strategies, and biomanufacturing breakthroughs. - [Idebenone Skincare Science: Decoding the Golden Key to Younger Skin](https://www.tianmingpharm.com/idebenone-skincare-science-decoding-the-golden-key-to-younger-skin/): This article explores Idebenone, a supercharged antioxidant surpassing Vitamins C/E. It details its molecular advantages, anti-aging efficacy, and practical usage tips. Learn to select high-purity Idebenone products. - [5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid](https://www.tianmingpharm.com/5-methyl-2-2h-123-triazol-2-ylbenzoic-acid/): CAS No.956317-36-5 - [Tianming Pharmaceutical Group Sincerely Invites You to Visit CPHI China 2025 - Our Booth No.: W2G30](https://www.tianmingpharm.com/tianming-pharmaceutical-group-sincerely-invites-you-to-visit-cphi-china-2025-our-booth-no-w2g30/): As a leading API/intermediate manufacturer, we showcase advanced synthesis tech and regulatory-ready solutions at CPHI 2025. Booth No.: W2G30 - [Navigating the Intricacies of API Synthesis: Insights from a Seasoned Chemist](https://www.tianmingpharm.com/navigating-the-intricacies-of-api-synthesis-insights-from-a-seasoned-chemist/): Expert analysis of API synthesis complexities: route selection trade-offs, scale-up challenges, impurity control tactics, and green chemistry innovations. Includes industrial case studies on yield optimization and troubleshooting. - [Pharmaceutical Ingredient List Mastery: Optimizing API Sourcing for Compliance & Innovation](https://www.tianmingpharm.com/pharmaceutical-ingredient-list-mastery-optimizing-api-sourcing-for-compliance-innovation/): This guide reveals why your Pharmaceutical Ingredient List is vital for compliance and innovation. Learn sourcing strategies, quality benchmarks, and 2024 API trend(Attached API list) - [Orforglipron vs GLP-1 Receptor Agonists: A Technical Comparison for Anti-Obesity API Sourcing](https://www.tianmingpharm.com/orforglipron-vs-glp-1-receptor-agonists-a-technical-comparison-for-anti-obesity-api-sourcing/): Analyzes molecular, manufacturing, and clinical distinctions between orforglipron and GLP-1 Receptor Agonists. Covers stability, scalability, and sourcing strategies for metabolic drug developers. - [Best PQQ Supplement Guide: Bioavailability, Stability & Manufacturing](https://www.tianmingpharm.com/best-pqq-supplement-guide-bioavailability-stability-manufacturing/): Analyzes critical quality markers for premium PQQ supplements: disodium salt bioavailability, stability assurance, and manufacturing red flags. Includes GMP production standards. - [Nicotinamide Riboside Chloride Powder: The Science Behind the NAD+ Revolution](https://www.tianmingpharm.com/nicotinamide-riboside-chloride-powder-the-science-behind-the-nad-revolution/): Analyzes nicotinamide riboside chloride's NAD+ boosting mechanism, therapeutic uses, production challenges (purity, stability), and key supplier selection criteria for supplement developers. Includes GMP manufacturing insights. - [Green Chemistry: The Pharma Industry’s Prescription for a Healthier Planet](https://www.tianmingpharm.com/green-chemistry-the-pharma-industrys-prescription-for-a-healthier-planet/): Green chemistry revolutionizes pharma API production by slashing waste (E-Factor), replacing toxic solvents, and cutting energy use. Tianming demonstrates eco-efficient catalytic innovation, water-based systems, and closed-loop recycling for sustainable drug manufacturing. - [Tianming Pharma: Powering the Oral GLP-1 Revolution with Orforglipron Intermediates](https://www.tianmingpharm.com/blog-tianming-pharma-powering-the-oral-glp-1-revolution-with-orforglipron-intermediates/): Tianming Pharma pioneers Orforglipron intermediates for oral GLP-1 drugs, enabling cold chain-free obesity/diabetes therapies. Backed by China’s policy & scaled cGMP production, we power global partners to reshape markets with innovation. - [The Active Pharmaceutical Ingredient (API) Market: Trends, Challenges & Strategic Sourcing](https://www.tianmingpharm.com/blog-the-active-pharmaceutical-ingredient-api-market-trends-challenges-strategic-sourcing/): Analyzing the evolving API market: covers geographic shifts, technical challenges like continuous processing, and critical supplier selection criteria. Includes regulatory updates and specialty API capabilities. - [Navigating the Avibactam Sodium API Market: Trends, Challenges, and Strategic Sourcing](https://www.tianmingpharm.com/blog-navigating-the-avibactam-sodium-api-market-trends-challenges-and-strategic-sourcing/): Analyzing the avibactam sodium API market: Covers synthesis innovations, regulatory hurdles, and supplier selection criteria for β-lactamase inhibitor production. Includes technical benchmarks for stability and combination therapies. - [Unraveling the Calcium Channel Blocker Showdown for Hypertension and Angina](https://www.tianmingpharm.com/nifedipine-vs-amlodipine-unraveling-the-calcium-channel-blocker-showdown-for-hypertension-and-angina/): Comparing Verapamil vs Diltiazem: Onset, duration, and side effects decoded. Demand for intermediates? We deliver quality. - [Tert-butyl((3s)-1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-2,6-dioxo-2,3,4,5,6,7-hexahydro-1h-purin-8-yl)piperidin-3-yl)carbaMate](https://www.tianmingpharm.com/lingaliptin-intermediates/): CAS No. 668273-75-4 - [Acetoxy Empagliflozin](https://www.tianmingpharm.com/acetoxy-empagliflozin/): CAS No. 915095-99-7 - [Dapagliflozin Tetraacetate](https://www.tianmingpharm.com/dapagliflozin-tetraacetate/): CAS No. 461432-25-7 - [(Rac)-Finerenone](https://www.tianmingpharm.com/rac-finerenone/): CAS No. 1050477-27-4 - [Nicotinamide Adenine Dinucleotide/NAD](https://www.tianmingpharm.com/nicotinamide-adenine-dinucleotide-nad/): CAS No. 53-84-9 - [NADH, disodium salt](https://www.tianmingpharm.com/nadh-disodium-salt/): CAS No. 606-68-8 - [5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid](https://www.tianmingpharm.com/s-orforglipron-carboxylic-acid-intermediate/): CAS No.2212021-83-3 - [(S)-1-(4-fluoro-2-methyl-2H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1H-imidazol-2(3H)-one](https://www.tianmingpharm.com/orforglipron-intermediate/): CAS No.2212022-56-3 - [Hechi City Leaders Visit Tianming Pharmaceutical Headquarters to Discuss Innovation in Pharmaceutical Industry](https://www.tianmingpharm.com/hechi-city-leaders-visit-tianming-pharmaceutical-headquarters-to-discuss-innovation-in-pharmaceutical-industry/): Hechi Vice Mayor Chen Zhijie toured Tianming Pharmaceutical’s facilities, praising its R&D strength and the “Jinan R&D + Hechi production” model. - [Orforglipron](https://www.tianmingpharm.com/orforglipron/): CAS No.2212020-52-3 ## Pages - [Success](https://www.tianmingpharm.com/success/): Thank you! Your message has been sent successfully. We will contact you shortly. Back home - [Others](https://www.tianmingpharm.com/others/): Others We provide high-quality APIs and intermediates for various pharmaceutical needs, and offer reliable pharmaceutical production solutions. Categories Others (3S,5S)-(5-methyl-piperidin-3-yl)-carbamic acid tert-butyl ester CAS No. 951163-61-4 View details 4-(3′-Methylphenyl)amino-3-pyridinesulfonamide CAS No. 72811-73-5 View details 5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile CAS No. 1240948-77-9 View details 4-Nitrophenethylamine hydrochloride CAS No. 29968-78-3 View details Bisoxatin Acetate CAS No.14008-48-1 View details 2-[2-(2-fluorophenyl)-2-oxoethyl]malononitrile CAS No.312307-38-3 View details 5-Pyrimidinol, 2,4-dimethyl- (9CI) CAS No.412003-95-3 View details (1R)-3-chloro-1-phenylpropanol CAS No.100306-33-0 View details 2-Bromo-2′-fluoroacetophenone CAS No.655-15-2 View details Lemborexant CAS No.1369764-02-2 View details 1 2 - [Food Raw Materials ](https://www.tianmingpharm.com/food-raw-materials/): Food Raw Materials We focus on purity, safety, and innovation, ensuring consistent quality for everyday wellness solutions. Categories Food Raw Materials L-Carnosine CAS No. 305-84-0 View details TPP-Thiazole CAS No. 1352002-58-4 View details Nicotinamide riboside malate CAS No. 2415659-01-5 View details β-Nicotinamide Mononucleotide(NMN) CAS No.1094-61-7 View details Ethyl nicotinate CAS No.614-18-6 View details Nicotinamide Riboside Chloride  CAS No.23111-00-4 View details Idebenone  CAS No.58186-27-9 View details Pyrroloquinoline quinone disodium salt CAS No. 122628-50-6 View details - [Cardiovascular  ](https://www.tianmingpharm.com/cardiovascular/): Cardiovascular Our cardiovascular APIs and intermediates are manufactured to the highest standards, enabling the safe, effective health treatments. Categories Cardiovascular 6-fluorochroman-2-carboxylic acid CAS No.99199-60-7 View details (2R,4S)-4-Amino-5-(biphenyl-4-yl)-2-methylpentanoic Acid Ethyl Ester Hydrochloride CAS No.149690-12-0 View details Ethyl 2-(triphenylphosphoranylidene)propionate CAS No. 5717-37-3 View details Sacubitril Sodium CAS No. 149690-05-1 View details Sacubitril Calcium CAS No.1369773-39-6 View details (2R,4S)-5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid CAS No.1012341-50-2 View details N-[(1R)-2-[1,1′-Biphenyl]-4-yl-1-(hydroxymethyl)ethyl]carbamic acid 1,1-dimethylethyl ester CAS No.1426129-50-1 View details (R,E)-4-Boc-amino-2-methyl-5-(biphenyl-4-yl)-2-pentenoic acid LCZ696 intermediate CAS No. 1012341-48-8 View details Sacubitril Valsartan CAS No. 936623-90-4 View details - [Antibiotics](https://www.tianmingpharm.com/antibiotics/): Antibiotics Our antibiotic APIs and intermediates offer broad-spectrum efficacy, ensuring reliable infection control. Categories Antibiotics Avibactam sodium CAS No.1192491-61-4 View details Avibactam CAS No.1192500-31-4 View details Avibactam INT 1 CAS No.1416134-48-9 View details Posaconazole CAS No.171228-49-2 View details Sulbenicillin sodium CAS No.28002-18-8 View details - [Anti-diabetic  ](https://www.tianmingpharm.com/anti-diabetic/): Anti-diabetic We provide anti-diabetic APIs and intermediates with a focus on consistent quality and supply. Categories Anti-diabetic Orforglipron CAS No.2212020-52-3 View details (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran CAS No.915095-89-5 View details 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone CAS No.32384-65-9 View details (5-Bromo-2-chlorophenyl)(4-fluorophenyl)methanone CAS No.915095-85-1 View details 5-bromo-2-chloro-4’-ethoxydiphenylmethane CAS No.461432-23-5 View details (R)-3-Piperidinamine dihydrochloride CAS No.334618-23-4 View details 8-bromo-7-but-2-yn-1-yl-3-methyl-3,7-dihydro-1H-purine-2,6-dione CAS No.853029-57-9 View details 8-bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione CAS No.666816-98-4 View details 2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile CAS No.865758-96-9 View details Mirabegron CAS No.223673-61-8 View details 1 2 3 - [Veterinary Drugs](https://www.tianmingpharm.com/veterinary-drugs/): Veterinary Drugs Our veterinary drug APIs and intermediates cater to animal health, offering precision and quality for effective treatments. Categories Veterinary Drugs Cephapirin Benzathine CAS No.97468-37-6 View details Ceftiofur sodium CAS No.104010-37-9 View details - [Anti-tumor](https://www.tianmingpharm.com/anti-tumor/): Anti-tumor Our antitumor APIs and intermediates are meticulously produced to ensure superior quality for oncology drugs. Categories Anti-tumor AZD-9291 CAS No.1421373-65-0 View details Sotorasib (AMG-510) CAS No.2296729-00-3 View details Adagrasib CAS No.2326521-71-3 View details Niraparib tosylate CAS No.1613220-15-7 View details Brigatinib CAS No.1197953-54-0 View details Osimertinib mesylate CAS No.1421373-66-1 View details Ibrutinib CAS No.936563-96-1 View details - [Anti-inflammatory](https://www.tianmingpharm.com/anti-inflammatory/): Anti-inflammatory We supply top-grade APIs and intermediates for anti-inflammatory drugs, ensuring fast and effective results. Categories Anti-inflammatory Dapoxetine hydrochloride CAS No.129938-20-1 View details (R)-α-[2-(1-naphthalenyloxy)ethyl]-benzeneMethanol CAS No.156453-53-1 View details (1R)-3-Chloro-1-phenyl-propan-1-ol CAS No.100306-33-0 View details Tofacitinib citrate CAS No.540737-29-9 View details Nafamostat mesylate CAS No.82956-11-4 View details - [Antiviral   ](https://www.tianmingpharm.com/antiviral/): Antiviral We deliver potent antiviral APIs and intermediates that enable the creation of highly effective medications solution. Categories Antiviral 7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol CAS No. 1985607-83-7 View details Pyrrolo[2,1-f][1,2,4]triazin-4-amin CAS No.159326-68-8 View details Tenofovir Alafenamide CAS No.379270-37-8 View details Tenofovir alafenamide hemifumarate CAS No.1392275-56-7 View details Molnupiravir CAS No.2349386-89-4 View details Baloxavir marboxil CAS No.1985606-14-1 View details Baricitinib CAS No.1187594-09-7 View details - [Antiplatelet Aggregation](https://www.tianmingpharm.com/antiplatelet-aggregation/): Antiplatelet Aggregation Our APIs and intermediates for antiplatelet drugs ensure high purity and efficacy, helping to deliver reliable cardiovascular treatments. Categories Antiplatelet Aggregation 4,6-dichloro-2-propylthiopyrimidine-5-amine CAS No.145783-15-9 View details - [Pharmaceutical Patents](https://www.tianmingpharm.com/pharmaceutical-patents/): Pharmaceutical Patent Discover Our Patents for Pharmaceuticals and Pioneering Solutions in Drug Development. Invention Patents Innovative preparation methods for APIs and intermediates. Utility Model Patents Innovation and creation of pharmaceutical facilities and equipment. Autonomous Patent Authorization Independent ownership and control of patent rights. Development of New Product Implementation and improvement of production processes and methods. Product Process Improvement Improvement of existing product processes to meet more detailed needs. Innovation Project Research Host and conduct provincial-level technology innovation project research. Patents in Pharmaceutical Industry Table of Contents1 “We are committed to protecting our innovations through pharmaceutical patents while ensuring that they benefit […] - [CSR](https://www.tianmingpharm.com/csr/): Corporate Social Responsibility (CSR) Leading in pharmaceutical innovation, we prioritize sustainable practices, community welfare, and ethical production in CSR.   Corporate Social Responsibility (CSR) is integral to our mission, reflecting our commitment to ethical production, environmental sustainability, and community engagement. We prioritize reducing our environmental footprint by adopting green manufacturing practices and ensuring responsible sourcing of raw materials. Beyond compliance, we actively contribute to local communities through education, health initiatives, and economic support. Our approach to CSR not only aligns with industry standards but also embodies our core values, driving positive change while fostering long-term partnerships and trust. Our CSR […] - [History](https://www.tianmingpharm.com/history/): History Explore our Journey of Excellence in Pharmaceutical Manufacturing. Tianming Pharmaceuticals: to be a global pharmaceutical leader driven by innovation Tianming Pharmaceuticals is a high-tech enterprise focusing on the research and development, production and sales of new drugs. Our company owns three major production bases as well as two major R&D centers. In addition, the company has established sales subsidiaries in India and Bangladesh, and has established extensive business contacts with partners in many countries around the world. In the field of R&D, Tianming Pharmaceuticals has a R&D team of more than 100 professional talents, dedicated to the research and […] - [Infrastructure](https://www.tianmingpharm.com/infrastructure/): Infrastructure State-of-the-Art Production Equipment for Superior Pharmaceutical Intermediates and APIs. Manufacturing facilities Our facilities and cutting-edge technology ensure that we meet the highest standards of quality, safety, and efficiency. Reactors Our reactors, available in various capacities and materials, are designed for optimal chemical synthesis processes. They ensure precise control over reaction parameters, resulting in consistent product quality. Filtration Systems We employ advanced filtration systems to ensure the purity of our products. These systems efficiently remove impurities and by-products, maintaining the integrity of our pharmaceutical intermediates and APIs. Dryers Our drying equipment, including spray dryers and vacuum dryers, ensures that our […] - [CDMO](https://www.tianmingpharm.com/cdmo/): Expert CDMO for APIs and intermediates Partner with us to receive customized, high-quality CDMO services tailored to your needs. Contact us Our Services Research & Innovation Production & Manufacturing Quality Control & Assurance Supply Chain & Logistics Table of Contents1 Research & Innovation2 Production & Manufacturing3 Quality Control & Assurance4 Supply Chain & Logistics5 Research & Innovation6 Production & Manufacturing7 Quality Control & Assurance8 Supply Chain & Logistics Research & Innovation We specialize in the innovative development of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), providing tailored services to enhance the drug discovery process. Our sophisticated R&D platform enables rapid […] - [Blog](https://www.tianmingpharm.com/blog/): Blog Follow us for the latest trends, insights and innovations in the pharmaceutical industry. Five Key Elements of Pharmaceutical Intermediate Quality Control This article explores five critical elements that define successful quality systems.Tianming Pharmaceutical Group, quality is treated not as a cost but as an investment, ensuring … Read More → How to Select a GMP-Certified Pharmaceutical Intermediates Supplier (Authoritative Guide) This guide explains how to assess supplier quality systems, manufacturing technology, and reliability — helping pharmaceutical companies secure a trusted partner for long-term success. Read More → Chiral Intermediates: Unraveling the Molecular Asymmetry That Defines Modern Pharmaceuticals Explore chiral […] - [Contact](https://www.tianmingpharm.com/contact/): Contact us Have a question or need more information about our products and services? Our team is here to assist you. Reach out to us today! Table of Contents1 Connect with us2 Manufacturer of pharma raw materials3 Sales Department4 5 6 7 Production Base8 9 10 Connect with us Let us be your trusted partner in APIs and Intermediates Manufacturer of pharma raw materials We are a trusted manufacturer of high-quality Active Pharmaceutical Ingredients (APIs) and intermediates, committed to supporting the pharmaceutical industry with reliable and efficient solutions. With cutting-edge technology and a strong focus on quality control, our products […] - [Products](https://www.tianmingpharm.com/products/): Products Explore our comprehensive range of high-quality APIs and intermediates. What We Do Why choose Tianming? Choose us as your pharmaceutical raw material supplier and get the highest quality APIs, intermediates, industry expertise and dedicated customer support. Superior Product Quality and Innovation At Tianming Pharmaceutical, we are committed to providing only the highest quality products, prioritizing excellence in every aspect of our operations. Our rigorous quality inspection processes, combined with advanced production equipment, guarantee that every batch we produce meets stringent industry standards, ensuring reliability and safety. Furthermore, our innovative R&D center is dedicated to developing cutting-edge solutions, allowing us to […] - [About](https://www.tianmingpharm.com/about/): About us Leading manufacturer of high-quality APIs and pharmaceutical intermediates, ensuring innovation and reliability. Our History Company overview Tianming Pharmaceutical, founded in 2010, is a leading innovator in R&D, production, and sales of new drugs, including antibiotics, cardiovascular, diabetes, anti-tumor, anti-aging, and antiviral products. Leveraging our scientific expertise and industry experience, we deliver top-quality pharmaceuticals for research and production. Renowned for high-quality products, flexibility, and customer service, Tianming has global reach with production bases in China and sales companies in India and Bangladesh, partnering with manufacturers worldwide. Previous slide Next slide Previous slide Next slide What We Offer Our factory […] - [Home](https://www.tianmingpharm.com/): Excellence in Pharmaceutical ManufacturingAbout TianMingLeading the Way in Pharmaceutical InnovationExplore productsCustomized Solutions for Your Pharmaceutical NeedsExplore productsHigh-Quality Pharmaceutical Intermediates for a Healthier FutureExperience service Previous slide Next slide Excellence in Pharmaceutical Manufacturing Trust us for unparalleled expertise in pharmaceutical raw materials and pharmaceutical intermediates About TianmingLeading the Way in Pharmaceutical Innovation Our comprehensive range includes Cardiovascular, DiabetesAnti-Tumor, and Anti-Aging Solutions Explore productsHigh-Quality Pharmaceutical Intermediates for a Healthier Future Our commitment to quality and excellence ensures that our pharmaceutical intermediates meet the highest standards Explore productsCustomized Solutions for Your Pharmaceutical Needs Specializes in providing tailored pharmaceutical intermediates and custom synthesis services […] [comment]: # (Generated by Hostinger Tools Plugin)